ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation

October 21, 1994

Bennett, CCIRC Members Disagree On state Of Groups, Simons New Chairman

June 27, 1980

NCI Is Considering New Core Grants For Prostate, Breast Research Centers

April 19, 1991

In Brief: Senate Tracks Reauthorization n New Institute Bill, Waxman May Go Along: Abe Goldin Dies

August 19, 1988

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

DCBDC Advisors Table Gl SPORE Over Pancreatic Cancer Research Requirement

March 17, 1995